Connecticut engineers health fund sues pharmaceuticals for blocking generic Aggrenox
MLex Summary: The Welfare Plan of the International Union of Operation Engineers has filed a class action on behalf of end-payors alleging a pay-for-delay agreement over Boehringer Ingelheim's blood clot reducing drug Aggrenox. The fund argues...To view the full article, register now.
Already a subscriber? Click here to view full article